---
figid: PMC9000533__molecules-27-02082-sch001
figtitle: Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing
  VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System
organisms:
- Homo sapiens
- Mus musculus
- Hepatitis B virus
organisms_ner:
- NA
pmcid: PMC9000533
filename: molecules-27-02082-sch001.jpg
figlink: /pmc/articles/PMC9000533/figure/molecules-27-02082-sch001/
number: SF1
caption: Illustration of the preparation and the anti-metastatic HCC strategy of GalNAc-modified
  AHPMA and DMAEMA-based polymeric micelles carried with gene/chemotherapy through
  the VEGF/VEGFR signaling pathway.
papertitle: Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with
  Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System.
reftext: Xunan Li, et al. Molecules. 2022 Apr;27(7):2082.
year: '2022'
doi: 10.3390/molecules27072082
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: hepatocellular carcinoma | metastasis | ASGPR | gene therapy | VEGF/VEGFR2
  signaling pathway
automl_pathway: 0.7611514
figid_alias: PMC9000533__SF1
figtype: Supplemental figure
redirect_from: /figures/PMC9000533__SF1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9000533__molecules-27-02082-sch001.html
  '@type': Dataset
  description: Illustration of the preparation and the anti-metastatic HCC strategy
    of GalNAc-modified AHPMA and DMAEMA-based polymeric micelles carried with gene/chemotherapy
    through the VEGF/VEGFR signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RhB-Br
  - DMAEMA
  - AHMA
  - N-acetyl-galactosamine
  - 5-FU
  - GalNAc-pDMA
  - RhB
---
